S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
S&P 500   2,995.68 (+1.00%)
DOW   27,024.80 (+0.89%)
QQQ   193.52 (+1.27%)
AAPL   235.32 (-0.23%)
FB   188.89 (+3.06%)
MSFT   141.58 (+1.45%)
GOOGL   1,242.24 (+2.01%)
AMZN   1,767.38 (+1.78%)
CGC   20.10 (+6.57%)
NVDA   196.37 (+5.28%)
MU   46.46 (+3.54%)
BABA   175.29 (+2.41%)
GE   8.89 (+1.95%)
TSLA   257.89 (+0.36%)
AMD   30.72 (+0.62%)
T   37.90 (+1.15%)
F   9.07 (+2.83%)
ACB   3.76 (+7.12%)
PRI   123.67 (+1.81%)
NFLX   284.25 (-0.45%)
BAC   29.73 (+2.02%)
GILD   65.30 (+1.22%)
DIS   129.76 (+0.05%)
Log in

GlaxoSmithKline Stock Price, News & Analysis (LON:GSK)

GBX 1,655.60
-28.60 (-1.70 %)
(As of 10/15/2019 04:00 PM ET)
Today's Range
1,641.20
Now: GBX 1,655.60
1,684
50-Day Range
1,627.20
MA: GBX 1,689.51
1,745.20
52-Week Range
1,408.80
Now: GBX 1,655.60
1,770.60
Volume9.19 million shs
Average Volume9.12 million shs
Market Capitalization£82.59 billion
P/E Ratio18.64
Dividend Yield4.55%
BetaN/A
GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Read More…

Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-80475000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£31.76 billion
Cash FlowGBX 82.04 per share
Book ValueGBX 73 per share

Profitability

Miscellaneous

Employees95,490
Outstanding Shares4,988,720,128
Market Cap£82.59 billion
Next Earnings Date10/30/2019 (Estimated)
OptionableOptionable

Receive GSK News and Ratings via Email

Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter.


GlaxoSmithKline (LON:GSK) Frequently Asked Questions

What is GlaxoSmithKline's stock symbol?

GlaxoSmithKline trades on the London Stock Exchange (LON) under the ticker symbol "GSK."

How often does GlaxoSmithKline pay dividends? What is the dividend yield for GlaxoSmithKline?

GlaxoSmithKline declared a dividend on Wednesday, July 24th. Investors of record on Thursday, August 8th will be given a dividend of GBX 19 per share on Thursday, October 10th. This represents a yield of 1.13%. The ex-dividend date is Thursday, August 8th. The official announcement can be accessed at this link. View GlaxoSmithKline's Dividend History.

How were GlaxoSmithKline's earnings last quarter?

GlaxoSmithKline plc (LON:GSK) announced its quarterly earnings results on Wednesday, April, 25th. The company reported $24.60 earnings per share for the quarter, topping the consensus estimate of $24.30 by $0.30. View GlaxoSmithKline's Earnings History.

When is GlaxoSmithKline's next earnings date?

GlaxoSmithKline is scheduled to release their next quarterly earnings announcement on Wednesday, October 30th 2019. View Earnings Estimates for GlaxoSmithKline.

What price target have analysts set for GSK?

16 brokers have issued 1-year target prices for GlaxoSmithKline's shares. Their forecasts range from GBX 1,510 to GBX 2,110. On average, they expect GlaxoSmithKline's stock price to reach GBX 1,708.93 in the next twelve months. This suggests a possible upside of 3.2% from the stock's current price. View Analyst Price Targets for GlaxoSmithKline.

What is the consensus analysts' recommendation for GlaxoSmithKline?

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. There are currently 1 sell rating, 12 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for GlaxoSmithKline.

Has GlaxoSmithKline been receiving favorable news coverage?

Press coverage about GSK stock has been trending positive recently, according to InfoTrie. The research firm rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. GlaxoSmithKline earned a news impact score of 2.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for GlaxoSmithKline.

Who are some of GlaxoSmithKline's key competitors?

What other stocks do shareholders of GlaxoSmithKline own?

Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AstraZeneca (AZN), General Electric (GE), Vodafone Group (VOD), Intel (INTC), AT&T (T), Allergan (AGN), Bank of America (BAC), Pfizer (PFE), Lloyds Banking Group (LLOY) and BP (BP).

Who are GlaxoSmithKline's key executives?

GlaxoSmithKline's management team includes the folowing people:
  • Ms. Emma N. Walmsley, CEO & Director (Age 49)
  • Dr. Hal V. Barron, Chief Scientific Officer, Pres of R&D and Director (Age 56)
  • Mr. Simon P. Dingemans, Exec. Director (Age 55)
  • Mr. Jack Bailey, Pres of US Pharmaceuticals
  • Mr. Iain James Mackay, CFO & Exec. Director (Age 57)

How do I buy shares of GlaxoSmithKline?

Shares of GSK and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is GlaxoSmithKline's stock price today?

One share of GSK stock can currently be purchased for approximately GBX 1,655.60.

How big of a company is GlaxoSmithKline?

GlaxoSmithKline has a market capitalization of £82.59 billion and generates £31.76 billion in revenue each year. GlaxoSmithKline employs 95,490 workers across the globe.View Additional Information About GlaxoSmithKline.

What is GlaxoSmithKline's official website?

The official website for GlaxoSmithKline is http://www.gsk.com/.

How can I contact GlaxoSmithKline?

GlaxoSmithKline's mailing address is 980 Great West Road, BRENTFORD, TW8 9GS, United Kingdom. The company can be reached via phone at +44-20-80475000.


MarketBeat Community Rating for GlaxoSmithKline (LON GSK)

Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  924 (Vote Outperform)
Underperform Votes:  1,501 (Vote Underperform)
Total Votes:  2,425
MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. Vote "Outperform" if you believe GSK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GSK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Featured Article: Intrinsic Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel